Related references
Note: Only part of the references are listed.Prognostic Value of Secretoneurin in Patients With Severe Sepsis and Septic Shock: Data From the Albumin Italian Outcome Sepsis Study
Helge Rosjo et al.
CRITICAL CARE MEDICINE (2018)
CaMKII as a target for arrhythmia suppression
Julian Mustroph et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Exercise training prevents ventricular tachycardia in CPVT1 due to reduced CaMKII-dependent arrhythmogenic Ca2+ release
Ravinea Manotheepan et al.
CARDIOVASCULAR RESEARCH (2016)
Prognostic Value of Secretoneurin in Patients with Acute Respiratory Failure: Data from the FINNALI Study
Peder L. Myhre et al.
CLINICAL CHEMISTRY (2016)
Prognostic Value of Secretoneurin in Critically III Patients With Infections
Helge Rosjo et al.
CRITICAL CARE MEDICINE (2016)
Secretoneurin Is a Novel Prognostic Cardiovascular Biomarker Associated With Cardiomyocyte Calcium Handling
Anett Hellebo Ottesen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Secretoneurin as a marker for hypoxic brain injury after cardiopulmonary resuscitation
Julia Hasslacher et al.
INTENSIVE CARE MEDICINE (2014)
Molecular Basis of Calpain Cleavage and Inactivation of the Sodium-Calcium Exchanger 1 in Heart Failure
Pimthanya Wanichawan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
CaMKII inhibitors: from research tools to therapeutic agents
Patricia Pellicena et al.
FRONTIERS IN PHARMACOLOGY (2014)
Ca2+ current facilitation is CaMKII-dependent and has arrhythmogenic consequences
Donald M. Bers et al.
FRONTIERS IN PHARMACOLOGY (2014)
Toward a hierarchy of mechanisms in CaMKII-mediated arrhythmia
Kevin P. Vincent et al.
FRONTIERS IN PHARMACOLOGY (2014)
Intensive care unit mortality after cardiac arrest: the relative contribution of shock and brain injury in a large cohort
Virginie Lemiale et al.
INTENSIVE CARE MEDICINE (2013)
Allele-Specific Silencing of Mutant Myh6 Transcripts in Mice Suppresses Hypertrophic Cardiomyopathy
Jianming Jiang et al.
SCIENCE (2013)
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia
E. Di Pasquale et al.
CELL DEATH & DISEASE (2013)
Calmodulin-Dependent Protein Kinase II: Linking Heart Failure and Arrhythmias
Paari Dominic Swaminathan et al.
CIRCULATION RESEARCH (2012)
Secretogranin II; a Protein Increased in the Myocardium and Circulation in Heart Failure with Cardioprotective Properties
Helge Rosjo et al.
PLOS ONE (2012)
Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia
Nian Liu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Natriuretic peptides in heart failure: should therapy be guided by BNP levels?
Michelle O'Donoghue et al.
NATURE REVIEWS CARDIOLOGY (2010)
The Calcium/Calmodulin/Kinase System and Arrhythmogenic Afterdepolarizations in Bradycardia-Related Acquired Long-QT Syndrome
XiaoYan Qi et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2009)
Hypoxia up-regulates the angiogenic cytokine secretoneurin via an HIF-1α- and basic FGF-dependent pathway in muscle cells
Margot Egger et al.
FASEB JOURNAL (2007)
Share Paper
